"Intravitreal Injections" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The administration of substances into the VITREOUS BODY of the eye with a hypodermic syringe.
Concept/Terms
Intravitreal Injections- Intravitreal Injections
- Injection, Intravitreal
- Injections, Intravitreal
- Intravitreal Injection
Below are MeSH descriptors whose meaning is more general than "Intravitreal Injections".
Below are MeSH descriptors whose meaning is more specific than "Intravitreal Injections".
This graph shows the total number of publications written about "Intravitreal Injections" by people in Harvard Catalyst Profiles by year, and whether "Intravitreal Injections" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2008 | 0 | 1 | 1 |
2010 | 0 | 2 | 2 |
2011 | 0 | 16 | 16 |
2012 | 1 | 10 | 11 |
2013 | 1 | 11 | 12 |
2014 | 3 | 14 | 17 |
2015 | 2 | 36 | 38 |
2016 | 3 | 17 | 20 |
2017 | 0 | 21 | 21 |
2018 | 1 | 23 | 24 |
2019 | 1 | 25 | 26 |
2020 | 0 | 21 | 21 |
2021 | 0 | 19 | 19 |
2022 | 0 | 26 | 26 |
2023 | 0 | 14 | 14 |
2024 | 0 | 1 | 1 |
Below are the most recent publications written about "Intravitreal Injections" by people in Profiles.
-
Feasibility demonstration of a device for vitreous liquid biopsy incidental to intravitreal injection. PLoS One. 2024; 19(1):e0294526.
-
Evolution of macular atrophy in eyes with neovascular age-related macular degeneration compared to fellow non-neovascular eyes. Graefes Arch Clin Exp Ophthalmol. 2023 Dec; 261(12):3425-3436.
-
Extrascleral Extension of Uveal Melanoma Along Intravitreal Needle Tracts Associated With Periodic Anti-Vascular Endothelial Growth Factor Therapy for Neovascular Age-Related Macular Degeneration. JAMA Ophthalmol. 2023 08 01; 141(8):801-803.
-
Lesion area progression in eyes with neovascular age-related macular degeneration treated using a proactive or a reactive regimen. Eye (Lond). 2024 01; 38(1):161-167.
-
Intravitreal Therapy for Uveitic Macular Edema-Ranibizumab versus Methotrexate versus the Dexamethasone Implant: The MERIT Trial Results. Ophthalmology. 2023 09; 130(9):914-923.
-
Electroretinographic Responses in Retinopathy of Prematurity Treated Using Intravitreal Bevacizumab or Laser. Am J Ophthalmol. 2023 08; 252:275-285.
-
Ten-Year Incidence of Fibrosis and Risk Factors for Its Development in Neovascular Age-Related Macular Degeneration. Am J Ophthalmol. 2023 08; 252:170-181.
-
Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial. Eye (Lond). 2023 12; 37(17):3551-3557.
-
SYRINGE DESIGN AND FILLING TECHNIQUE AFFECT ACCURACY OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INTRAVITREAL INJECTIONS. Retina. 2023 03 01; 43(3):514-519.
-
CATASTROPHIC, BILATERAL RETINAL VASCULAR OCCLUSION AFTER INTRAVITREAL BEVACIZUMAB INJECTION. Retin Cases Brief Rep. 2023 Mar 01; 17(2):81-84.